Eiffel names CEO as executive director
Monday, 02 June, 2003
Eiffel Technologies' CEO Christine Cussen has joined the company's board as an executive director.
Formerly managing director of AstraZeneca Pharmaceuticals, Cussen joined Melbourne-based Eiffel in October 2000 to oversee the development and commercialisation of the company's supercritical fluid technologies.
"She has brought strong professional marketing and management expertise to Eiffel at a time when we were seeking to increase the exposure of our technologies to our customer base and international pharmaceutical companies worldwide. She is a very valued employee and we recognise that she will make a significant contribution at Board level to the success of the company," said chairman Tom Hartigan.
Simulated microgravity affects sleep, physiological rhythms
The simulated effects of microgravity significantly affect rhythmicity and sleep in humans, which...
Hybrid insulin pumps work well for type 1 diabetes
Advanced hybrid closed loop (AHCL) insulin pumps are designed to constantly measure blood sugar...
3D-printed films provide targeted liver cancer treatment
Researchers have created drug-loaded, 3D-printed films that kill more than 80% of liver cancer...